Product Reports Resources Pricing Login Book a demo

Molecubes

Biotech & Life Sciences · Ghent, Belgium · Founded 2015

Preclinical in-vivo imaging systems MoreLess

Molecubes, founded in 2015 as a spin-off from Ghent University-iMinds in Belgium, develops and manufactures modular benchtop preclinical imaging systems. The company was established by Professor Dr. Roel Van Holen, along with co-founders Pieter Mollet, Bert Vandeghinste, and Ewout Vansteenkiste, based on research to make complex molecular imaging technology more accessible. In January 2016, the company secured €1.9 million in seed funding to launch its initial products.

The company's core business is providing compact and user-friendly in-vivo imaging solutions for life science research. Its primary clients include academic and government research laboratories, pharmaceutical and biotechnology companies, and contract research organizations (CROs). The business model centers on the sale of its hardware, the 'CUBES', which are designed for high-performance imaging while maintaining a small footprint suitable for any lab bench. In November 2021, Molecubes was acquired by Bruker Corporation, a move intended to strengthen Bruker's preclinical imaging portfolio and expand the global reach of the CUBES technology. Molecubes continues to operate as an agile team within Bruker's BioSpin Preclinical Imaging division.

Molecubes offers three main products, each a separate benchtop imager that can be used as a standalone unit or in modular combination: the β-CUBE (a high-sensitivity micro-PET scanner), the γ-CUBE (a high-resolution micro-SPECT scanner), and the X-CUBE (a high-throughput, low-dose micro-CT scanner). These systems are designed for whole-body imaging of mice and rats, supporting research in fields like oncology, neurology, and cardiology. A key feature is their modularity, allowing researchers to perform PET/CT, SPECT/CT, or PET/SPECT/CT studies and enabling multiple users to work simultaneously. The systems are supported by intuitive, wireless software that simplifies workflows and makes advanced 3D imaging accessible to a broader range of researchers.

Keywords: preclinical imaging, molecular imaging, PET scanners, SPECT scanners, CT scanners, benchtop imagers, life science research, drug discovery, small animal imaging, modular imaging systems

Company overview

Molecubes company information

The essential company record, classifications and operating signals in one place.

Status
Acquired
Founded
2015
Headquarters
Ghent, Belgium
Employees
16
Open positions
None listed
Dealroom signal
66.6
client focusb2btechnologyArtificial Intelligenceclient focusb2ctechnologyHardwaretechnology3D TechnologytechnologyBig DatatechnologyDeep TechtechnologyComputer Visionsub industryBioTechnologybusiness modelManufacturingbusiness modelSaaSsectorIntellectual PropertyindustryHealthsectorAnalytics

Valuation & funding

Molecubes funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITIONExit Nov 2021 $0 Bruker
SEEDEquity / VC Jan 2016 $2.2M $8.8M Undisclosed
SPINOUTOther financing Jan 2015 $0 imec · Ghent University
Showing 3 recorded eventsUnlock the complete deal history →

Financials

Revenue, earnings and profit over time

Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.

YearEBITDAMarginProfitMargin
2026 $3M $3.1M
2025 $3M $3.1M
2024 $3M $3.1M
2023 $3M
2022 $3M
2021 $1.2M
2020 $1.7M
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Molecubes website traffic

Latest recorded traffic for Molecubes is 2.4K monthly website visits, up 3900% over the last three months. Molecubes's team declined 11.1% over the past year.

Latest monthly visits2.4K 3-month web change+3900% 1-year team growth-11.1%
Monthly website visits125 observations · Jun 2015–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Molecubes compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Molecubes's talent

Book a demo to see the people
Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 6 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

7 investors on Molecubes's cap table

Sourced from Dealroom's funding and investor records.

Other known 7 additional known investors
Bruker
Ghent University
imec
imec.istart
imec.istart future fund
Qbic Fund
Walter Mastelinck

Global footprint

Where Molecubes has talent and traffic

Workforce by country
3 countries with
team presence
🇧🇪 Belgium85.7%
🇫🇷 France7.1%
🇸🇬 Singapore7.1%
3 countries shown

In the news

Latest news about Molecubes

Recent press, funding announcements, and product moves mentioning Molecubes — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Molecubes

An AI-synthesized read of the highest-engagement posts about Molecubes on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Molecubes’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.